Major MeSH terms read more often by clinicians |
Frequency: clinician |
Frequency: random |
p-value |
diff |
Major MeSH terms occurring more often in a random sample |
Frequency: clinician |
Frequency: random |
p-value |
diff |
Pain/drug therapy |
0.0186 |
0.0010 |
0.0000 |
0.0176 |
Polymorphism, Genetic |
0.0003 |
0.0042 |
0.0000 |
−0.0038 |
Hip joint/surgery |
0.0154 |
0.0000 |
0.0000 |
0.0154 |
DNA-Binding Proteins/metabolism |
0.0002 |
0.0037 |
0.0000 |
−0.0035 |
Arthroscopy/methods |
0.0130 |
0.0002 |
0.0000 |
0.0129 |
Models, Chemical |
0.0002 |
0.0035 |
0.0000 |
−0.0033 |
Analgesics/opioids, therapeutic uses |
0.0135 |
0.0007 |
0.0000 |
0.0128 |
Genetic Variation |
0.0008 |
0.0035 |
0.0012 |
−0.0027 |
Meta-analysis as topic |
0.0122 |
0.0000 |
0.0000 |
0.0122 |
Transcription Factors/metabolism |
0.0005 |
0.0032 |
0.0005 |
−0.0027 |
Internet |
0.0133 |
0.0013 |
0.0000 |
0.0120 |
Bacterial Proteins/metabolism |
0.0000 |
0.0027 |
0.0000 |
−0.0027 |
Quality of life |
0.0133 |
0.0032 |
0.0000 |
0.0102 |
Plant Extracts/pharmacology |
0.0003 |
0.0025 |
0.0012 |
−0.0022 |
Physician–patient relationship |
0.0116 |
0.0017 |
0.0000 |
0.0099 |
Enzyme Inhibitors/pharmacology |
0.0002 |
0.0023 |
0.0006 |
−0.0022 |
Review literature as topic |
0.0098 |
0.0002 |
0.0000 |
0.0096 |
DNA/chemistry |
0.0000 |
0.0022 |
0.0002 |
−0.0022 |
Analgesics/opioids, adverse effects |
0.0087 |
0.0000 |
0.0000 |
0.0087 |
Polymorphism, Genetic |
0.0003 |
0.0042 |
0.0000 |
−0.0038 |
Minor MeSH terms read more often by clinicians |
Frequency: clinician |
Frequency: random |
p-value |
diff |
Minor MeSH terms occurring more often in a random sample |
Frequency: clinician |
Frequency: random |
p-value |
diff |
Humans |
0.8608 |
0.6027 |
0.0000 |
0.2581 |
Animals |
0.0754 |
0.2328 |
0.0000 |
−0.1574 |
Adult |
0.2979 |
0.1625 |
0.0000 |
0.1354 |
Mice |
0.0182 |
0.0675 |
0.0000 |
−0.0493 |
Female |
0.4321 |
0.3025 |
0.0000 |
0.1296 |
Rats |
0.0141 |
0.0458 |
0.0000 |
−0.0317 |
Male |
0.4216 |
0.2937 |
0.0000 |
0.1280 |
Molecular sequence data |
0.0035 |
0.0312 |
0.0000 |
−0.0276 |
Middle aged |
0.2692 |
0.1490 |
0.0000 |
0.1202 |
Cell line |
0.0031 |
0.0220 |
0.0000 |
−0.0189 |
Aged |
0.1868 |
0.1040 |
0.0000 |
0.0828 |
Amino acid sequence |
0.0014 |
0.0193 |
0.0000 |
−0.0179 |
Treatment outcome |
0.0989 |
0.0515 |
0.0000 |
0.0474 |
Cells, cultured |
0.0048 |
0.0217 |
0.0000 |
−0.0168 |
Adolescent |
0.1100 |
0.0690 |
0.0000 |
0.0410 |
Base sequence |
0.0031 |
0.0185 |
0.0000 |
−0.0154 |
Elderly: 80 and over |
0.0722 |
0.0388 |
0.0000 |
0.0333 |
Cell line, tumor |
0.0034 |
0.0170 |
0.0000 |
−0.0136 |
Prospective studies |
0.0548 |
0.0240 |
0.0000 |
0.0308 |
Kinetics |
0.0016 |
0.0152 |
0.0000 |
−0.0136 |